News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
86,022 Results
Type
Article (5367)
Company Profile (15)
Press Release (80638)
Multimedia
Podcasts (16)
Webinars (1)
Section
Business (25452)
Career Advice (128)
Deals (3117)
Drug Delivery (26)
Drug Development (11126)
Employer Resources (11)
FDA (1775)
Job Trends (2139)
News (38386)
Policy (2873)
Tag
2025 Best Places to Work (3)
2026 Best Places to Work (3)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (640)
Accelerated approval (16)
ADA (8)
Adcomms (2)
Allergies (33)
Alliances (6199)
ALS (48)
Alzheimer's disease (440)
Antibody-drug conjugate (ADC) (123)
Approvals (2034)
Artificial intelligence (285)
ASCO (44)
Autoimmune disease (120)
Automation (20)
Bankruptcy (20)
Belgium (14)
Best Places to Work (1958)
BIO (9)
Biologics (30)
Biosimilars (42)
BioSpace Insights (34)
Biotechnology (8)
Bispecific (12)
Bladder cancer (36)
Brain cancer (24)
Breast cancer (151)
Cancer (1347)
Cardiovascular disease (125)
Career advice (121)
Career pathing (8)
CAR-T (47)
CDC (9)
CDMO (43)
Celiac Disease (1)
Cell-line development (1)
Cell therapy (184)
Cervical cancer (11)
Clinical research (10468)
Collaboration (656)
Commercialization (26)
Company closure (1)
Compensation (80)
Complete response letters (15)
COVID-19 (351)
CRISPR (41)
CRO (1)
C-suite (540)
Cystic fibrosis (182)
Data (2328)
Decentralized trials (1)
Denatured (11)
Depression (31)
Dermatology (75)
Diabetes (115)
Diagnostics (987)
Digital health (13)
Diversity (3)
Diversity, equity & inclusion (4)
Drug discovery (136)
Drug pricing (21)
Drug shortages (1)
Duchenne muscular dystrophy (74)
Earnings (7911)
Editorial (8)
Employer branding (2)
Employer resources (10)
ESMO (63)
Events (12086)
Executive appointments (383)
Eye disease (1)
FDA (2707)
Fibrodysplasia Ossificans Progressiva (1)
Fragile X (4)
Friedreich's ataxia (4)
Frontotemporal dementia (5)
Funding (696)
Gene editing (73)
Generative AI (29)
Gene therapy (168)
GLP-1 (216)
Government (553)
Guidances (69)
Healthcare (2825)
Hematology (43)
HIV (49)
Huntington's disease (12)
Idiopathic pulmonary fibrosis (16)
IgA nephropathy (63)
Immunology and inflammation (44)
Immuno-oncology (25)
Indications (78)
Infectious disease (445)
Inflammatory bowel disease (94)
Inflation Reduction Act (2)
Influenza (24)
Intellectual property (105)
Interviews (14)
IPO (1543)
IRA (2)
Job creations (237)
Job search strategy (99)
JPM (7)
Kidney cancer (2)
Kidney disease (68)
Labor market (12)
Layoffs (53)
Leadership (7)
Legal (453)
Licensing (23)
Liver cancer (22)
Longevity (20)
Lung cancer (164)
Lung diease (12)
Lymphoma (96)
Machine learning (24)
Management (3)
Manufacturing (280)
Marketing (7)
MASH (196)
Medical affairs (2)
Medical device (1366)
Medtech (1418)
Melanoma (34)
Mergers & acquisitions (1857)
Metabolic disorders (411)
Middle East (1)
mRNA (81)
Multiple sclerosis (27)
Multispecific (2)
NASH (20)
Netherlands (8)
Neurodegenerative disease (139)
Neuropsychiatric disorders (12)
Neuroscience (901)
Neurotech (1)
NextGen: Class of 2026 (976)
Non-profit (2494)
Now hiring (9)
Obesity (111)
Opinion (58)
Ovarian cancer (58)
Pain (33)
Pancreatic cancer (89)
Parkinson's disease (183)
Partnered (5)
Patents (191)
Patient advocacy (3)
Patient recruitment (185)
Patient selection (31)
Peanut (12)
People (10201)
Peptides (14)
Pharmaceutical (6)
Pharmacy benefit managers (6)
Phase 1 (3092)
Phase 2 (5000)
Phase 3 (3420)
Pipeline (3312)
Policy (36)
Postmarket research (283)
Preclinical (1419)
Press Release (15)
Prostate cancer (68)
Psychedelics (7)
Radiopharmaceuticals (56)
Rare diseases (475)
Real estate (505)
Recruiting (2)
Regenerative medicine (7)
Regulatory (3111)
Reports (6)
Research institute (625)
Resumes & cover letters (15)
Rett syndrome (13)
RNA editing (5)
RSV (24)
Saudi Arabia (1)
Schizophrenia (37)
Series A (113)
Series B (64)
Series C (1)
Sickle cell disease (38)
Special edition (4)
Spinal muscular atrophy (88)
Sponsored (11)
Startups (602)
Stem cells (2)
Stomach cancer (1)
Substance use disorders (5)
Supply chain (18)
Switzerland (3)
Tariffs (2)
The Weekly (5)
Vaccines (171)
Venture capital (34)
Weight loss (57)
Wet AMD (1)
Women's health (44)
Women in leadership (1)
Worklife (2)
Date
Last 7 days (159)
Last 30 days (752)
Last 365 days (6427)
2026 (5987)
2025 (4767)
2024 (4911)
2023 (5668)
2022 (6759)
2021 (7814)
2020 (7535)
2019 (7003)
2018 (5197)
2017 (3987)
2016 (3926)
2015 (4098)
2014 (2887)
2013 (2130)
2012 (2114)
2011 (2182)
2010 (1642)
Location
Africa (112)
Alabama (7)
Alaska (2)
Arizona (63)
Arkansas (2)
Asia (4548)
Australia (872)
California (2866)
Canada (655)
China (294)
Colorado (107)
Connecticut (241)
Delaware (83)
Europe (11760)
Florida (377)
Georgia (144)
Idaho (10)
Illinois (237)
India (28)
Indiana (82)
Iowa (12)
Japan (151)
Kansas (17)
Kentucky (11)
Louisiana (7)
Maine (7)
Maryland (331)
Massachusetts (2113)
Michigan (59)
Minnesota (68)
Mississippi (2)
Missouri (57)
Montana (11)
Nebraska (6)
Nevada (41)
New Hampshire (14)
New Jersey (651)
New Mexico (6)
New York (820)
North Carolina (335)
North Dakota (4)
Northern California (1493)
Ohio (93)
Oklahoma (6)
Oregon (10)
Pennsylvania (551)
Puerto Rico (4)
Rhode Island (12)
South America (111)
South Carolina (12)
South Dakota (1)
Southern California (1167)
Tennessee (39)
Texas (458)
United States (9880)
Utah (91)
Virginia (63)
Washington D.C. (12)
Washington State (200)
West Virginia (1)
Wisconsin (31)
86,022 Results for "cystic fibrosis foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
C-suite
ReCode CEO Suliman leaves cystic fibrosis mission in mentee’s hands
After achieving clinical validation earlier this year, ReCode Therapeutics has called up a new CEO to take on the mission of advancing programs for cystic fibrosis and primary ciliary dyskinesia through the clinic.
September 23, 2026
·
3 min read
·
Annalee Armstrong
Cystic fibrosis
Sionna’s cystic fibrosis failure is a windfall for Vertex’s blockbuster franchise
A surprise flop in Phase 2a cystic fibrosis trial sent Sionna’s shares plummeting, but for Vertex, the news reinforced its standard-of-care standing with highly successful drugs like Trikafta.
August 10, 2026
·
2 min read
·
Michael Gibney
Press Releases
Ride Therapeutics Announces up to US$7.3 Million Investment from the Cystic Fibrosis Foundation to Advance Next-Generation Genetic Medicines
September 10, 2026
·
3 min read
Press Releases
Enterprise Therapeutics Granted EMA Orphan Medicinal Product Designation for Novel Cystic Fibrosis Therapy, ETD001
November 17, 2026
·
2 min read
Press Releases
ReCode Therapeutics Announces New Funding from the Cystic Fibrosis Foundation, Collaboration with a Leading Gene Editing Company and Leadership Transition
August 6, 2026
·
5 min read
Press Releases
Sionna Therapeutics to Present Data at the 2026 North American Cystic Fibrosis Conference
October 8, 2026
·
6 min read
Press Releases
Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference
October 12, 2026
·
14 min read
Press Releases
Aptar and Aceso Therapeutics Announce Collaboration to Advance Inhaled Antisense Oligonucleotide Therapy for Cystic Fibrosis
September 7, 2026
·
4 min read
Press Releases
Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update
August 10, 2026
·
7 min read
Cystic fibrosis
Arcturus Plunges on ‘Mixed’ Cystic Fibrosis Data for Inhaled mRNA Drug
Despite showing no meaningful benefit on lung function, Arcturus’ mRNA therapy ARCT-032 reduced mucus volume in patients with cystic fibrosis—an outcome William Blair found “potentially promising.”
October 23, 2025
·
2 min read
·
Tristan Manalac
1 of 8,603
Next